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In December 2011, a 42-year-old male farmer was admitted to a hospital in
Sanandaj (Western Iran) with fever and anemia in order to check whether he
suffered from some infectious diseases. During the first 3 days after admission,
the patient gradually developed progressive oliguria, fever, abdominal pain in
the right upper quadrant, leukocytosis with toxic granulation, petechiae and
ecchymosis, oral bleeding, and vomiting. The sonographic findings revealed
splenomegaly and an increase in the thickness of the gall bladder wall. In order
to manage the patient and taking into consideration the most probable differ-
ential diagnoses, diagnostic tests were performed on two blood samples
collected from him, and real-time polymerase chain reaction for human cyto-
megalovirus was positive.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
0) which permits unrestricted non-commercial use, distribution, and reproduction in any
roperly cited.
are listed alphabetically.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
Figure 1. Petechiae and ecchymosis in the upper limbs of the
patient. Petechiae were seen on the 2nd day until the 16th day
post admission.
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Human cytomegalovirus (HCMV) is a member of the
Betaherpesvirinae subfamily of Herpesviridae, with
double-stranded linear DNA genomes. There are many
ways of detecting this family in the blood or sera [1].
This virus has a worldwide distribution. Between 40%
and 100% of adults from different populations become
infected by the 4th decade of life [2]. This virus can cause
acute infection and serious complications in immuno-
compromised people, especially in transplanted patients
or in pregnant women (which can cause fetal anomalies).
Most HCMV infections in immunocompetent people are
asymptomatic, and some produce a mononucleosis-like
syndrome [3]. There have been reports of severe hemo-
lytic anemia, severe thrombocytopenia, and various
types of hemorrhage in some HCMV patients [4].
In the present study, an uncommon case of acute
infection, which was caused by HCMV and involved
multiple organs, is outlined. Reactivation of CMV oc-
curs frequently in critically ill, immunocompetent pa-
tients and is associated with prolonged hospitalization or
death.2. Case report
On December 26, 2011, a man was admitted to Tohid
hospital in Sanandaj (Western Iran), for the removal of
kidney stones, with the following profile: farmer, 42
years old, diabetic, and resident of a village near San-
andaj, Iran. The patient had a fever of 38.9C (102F)
and appeared anemic on early examination.
The patient had no history of hepatic, renal, vascular,
or digestive system disorders. He consumed rabbit meat
2e3 weeks prior to admission. There were no significant
findings on clinical examination of the cardiovascular
system, pulmonary system, or abdomen, but he was
restless and suffering from dizziness on admission. Over
the first 3 days post admission, the patient gradually
developed progressive oliguria, fever, abdominal pain in
the right upper quadrant, leukocytosis with toxic granu-
lation (in peripheral blood smear), petechiae and ecchy-
mosis (Figure 1), oral bleeding, and vomiting. On an
initial sonographic examination to evaluate the patient
for the possibility of cholangitis, the spleen was found to
be larger than usual (150 mm) and the thickness of the
gall bladder wall was increased. The right kidney was
larger than normal, and its corticomedullary echo was
increased. On the 3rd day post admission, there were
severe thrombocytopenia and increases in creatinine,
alkaline phosphatase, bilirubin, and hepatic enzymes
(alanine aminotransferase and aspartate aminotrans-
ferase; Table 1). Over the next few days, the patient’s
consciousness decreased, and he became disoriented with
respect to time and place. Gradually, by the 7th day, the
patient developed myalgia and hematuria, and becameicteric. On the following day, icterus decreased. On the
9th day, consciousness levels improved and his general
condition gradually improved over the next few days.
Blood and urine cultures were negative during hospi-
talization. After admission, the patient was treated with
supportive therapies, including blood transfusion, antibi-
otic therapy (ciprofloxacin, ampicillin/sulbactam, and
metronidazole; from the 2nd day), receipt of fresh frozen
plasma (from the 6th day), dialysis (from the 7th day), and
administration of dexamethasone 8 mg Q, which was
gradually tapered to 4 mg Q 12 hours (from the 12th day
until discharge). The fever gradually diminished from the
13th day; dexamethasone dosewas tapered and intravenous
antibiotic therapy changed to cefixime and metronidazole.
The patient was transferred from an intensive care
unit isolation ward to an infectious disease ward, on
January 11, 2012. Meanwhile, the patient’s platelet
count was >85,000 and bleeding had stopped. On
January 18, 2012, he was discharged with complete re-
covery after 23 days. The patients did not receive any
antiviral treatment during his stay in the hospital.
The patient returned to the hospital for renal stone
removal after 1 month and was operated upon. He was
discharged with complete recovery after 48 hours. After
1 year, the patient was monitored, and he had no major
medical problems.
The blood and serum samples were referred to the
Department of Epidemiology of the Pasteur Institute of
Iran on December 31, 2011 (the 5th day of admission)
and January 18, 2012 (discharge day). The samples were
sent to the relevant laboratories of the Pasteur Institute
of Iran, to test for CrimeaneCongo hemorrhagic fever
(CCHF), hantavirus (Seoul, Khabarovsk, and Puumala),
dengue fever, plague, tularemia, and leptospirosis. A
survey of antihepatitis A virus antibody had already
been carried out in the Tohid hospital (on the 2nd day
post admission).3. Results
The results of the tests on the first blood samples were
negative for CCHF [enzyme-linked immunosorbent
Table 1. Hematological and biochemical test results from the 3rd day of admission until the recovery day.
Tested variable
Day of admission
3rd 4th 5th 8th 13th 23th
PTT d 30 d 30 39 d
PT d 12 d 12 13 d
INR d 1.2 d d 1.5 d
WBC 23.7 29.41 20 19.5 13.8 23.9
Hb 8 10.5 13 8.2 10.8 9.5
Plt (1000) 17 12 13 88 131 145
Neutrophil (%) 95 88 d d 94 d
Cr 10.2 9.4 9.9 7.4 4.5 3.3
Bili T d 29.9 19 7.1 5.3 4
Bili D 16.5 12.7 10.5 3.8 2.9 d
ALP 127 274 278 310 296 345
Na d d 140 120 130 d
K d d d d 4.9 d
AST d 52.5 57 130 d d
ALT d 40 35.5 129 d d
ALPZ alkaline phosphatase; ALTZ alanine aminotransferase; ASTZ aspartate aminotransferase; Bili DZ bilirubin, direct; Bili TZ bilirubin, total;
Cr Z serum creatinine; Hb Z hemoglobin; INR Z international normalized ratio; Plt Z platelets; PT Z prothrombin time; PTT Z partial throm-
boplastin time; WBC Z white blood cell.
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(RT-PCR], leptospirosis (ELISA and IFA), plague
(ELISA, RT-PCR, and rapid test), and tularemia (RT-
PCR). The patient’s second blood sample was rechecked
for leptospirosis, plague, tularemia, CCHF, hantavirus
(Seoul, Khabarovsk, and Puumala; RT-PCR), dengue
fever (ELISA and RT-PCR), HIV (ELISA rapid test),
and EpsteineBarr virus (RT-PCR), and all were
negative.
Tests for antihepatitis A antibodies was also carried
out for the patient and his family, the results of which
were positive for the patient, his wife, and one of his
children, but immunoglobulin M was negative. Both test
results were negative for his two other children.
After receiving the negative results for all the above
infectious agents and according to the decision of the
infectious disease specialist, an HCMV test was carried
out on two blood samples (on the 5th day of admission to
the hospital and on the day of discharge from the hos-
pital), and the result of RT-PCR Primerdesign Ltd,
Southhampton, United Kingdom according to the man-
ufacture’s protocol, was positive for HCMV.
4. Discussion
As the patient had fever, hemorrhage, icterus, and
myalgia, along with abnormalities in the hepatic enzyme
level and severe thrombocytopenia, which are indicative
of hemorrhagic fever diseases, the necessary laboratory
tests (for hantavirus, CCHF, dengue fever, and lepto-
spirosis) were performed on received sera samples.
Because the patient had been living in an area where
cases of tularemia and plague infection had been re-
ported many years ago, and as the patient reported rabbitmeat consumption 2e3 weeks prior to admission, the
samples were also tested for plague and tularemia.
Suspicion of hepatitis A was based on an elevation of
hepatic enzymes levels and its continuation over the
following few days. According to the patient’s condition
and based on the laboratory results, a microorganism
that was capable of causing acute multiple organ
dysfunction was searched for. While manifestations of
CMV infection in immunocompromised patients have
been reported extensively in the literature, little attention
has been paid to this infection in immunocompetent
patients. Several reasons must be considered for the
under-reporting of severe CMV infections in immuno-
competent hosts. One reason may be the rather moderate
accuracy of some routinely available diagnostic
methods, such as serological tests. By contrast, molec-
ular diagnostic methods, such as PCR, which are more
commonly used in immunocompromised patients appear
to be more sensitive and specific than serological or
virus isolation tests [5]. There are relatively few studies
evaluating the incidence of severe CMV disease in
immunocompetent patients; in a study among 116
immunocompetent adults with acute CMV infection,
1.7% developed severe complications [6]. In another
cohort study on 115 patients with acute CMV infection,
5.2% developed severe disease (including hematologic
manifestation) [7]. CMV infection or reactivation occurs
in 0e36% of the critically ill, but otherwise immuno-
competent, hosts in the intensive care unit. Sepsis is one
of the most frequently studied inciting events for CMV
infection in these patients [8]. HCMV was considered by
the infectious disease specialist, and the molecular test
of the patient’s serum later showed a positive result,
indicating an acute self-limiting infection caused by this
386 B. Pourhossein, et alvirus. It should be mentioned that acute CMV infection
only rarely causes these symptoms in patients [4,9].
Thrombocytopenia was reported in acute forms of CMV
infection in immunocompetent persons in several
studies, which parallels the findings of this case [4]. The
acute clinical signs that were seen in this patient are
usually seen in immunocompromised persons or trans-
planted patients, yet this patient was immunocompetent.
Because there were no documented findings of renal
damage caused by HCMV in an immunocompetent pa-
tient, the renal disorders in this case are probably due to
nephrolithiasis.
In general, the clinical process of the patient can be
divided into three phases. The 1st week consisted of mild
clinical signs and body temperature elevation. In the 2nd
week, organ dysfunctions (such as hepatic, neurologic,
hematologic, vascular, and renal dysfunctions) occurred,
and finally over the last 9 days there was improvement
in the patient’s condition with supportive therapies, and
he was discharged from the hospital. Severe life-
threatening complications of CMV infection in immu-
nocompetent patients may not be as rare as previously
thought. As multiple organ involvement is rarely seen in
acute CMV infection, consideration of this clinical
probability may assist physicians in accurate diagnosis
and appropriate treatment.Conflicts of interest
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